Literature DB >> 3064493

Stereotyped behaviour in animals induced by stimulant drugs or by a restricted cage environment: relation to disintegrated behaviour, brain dopamine and psychiatric disease.

A Randrup1, G Sørensen, M Kobayashi.   

Abstract

Stereotyped behaviour can be produced in animals both by stimulant drugs (amphetamine, methamphetamine, cocaine, etc.) and by a restricted cage environment. Strong evidence indicates that the effect of stimulant drugs is mediated through a primary effect on brain dopamine, and further knowledge is now being acquired through studies on dopamine receptors, tolerance and reverse tolerance to amphetamines and the neural connections of dopaminergic sub-systems with other sub-systems in the brain. The forms of stereotypy induced by a restricted cage environment have been compared with other effects of this type of environment on behaviour and general health. This has led to a hypothesis that stereotyped behaviour may function as a survival (or defence) strategy in an unfavourable milieu. Some evidence indicates that brain dopamine is also involved in the mediation of stereotyped behaviour induced by the environment. The relevance of these results in clinical psychiatry is discussed. Stereotypy (and related disintegrated behaviour) is a well known feature of several mental diseases.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3064493

Source DB:  PubMed          Journal:  Yakubutsu Seishin Kodo        ISSN: 0285-5313


  3 in total

1.  Methamphetamine-alcohol interactions in murine models of sequential and simultaneous oral drug-taking.

Authors:  Elissa K Fultz; Douglas L Martin; Courtney N Hudson; Tod E Kippin; Karen K Szumlinski
Journal:  Drug Alcohol Depend       Date:  2017-05-24       Impact factor: 4.492

2.  Alteration of Methamphetamine-induced stereotypic behaviour in transgenic mice expressing HIV-1 envelope protein gp120.

Authors:  Amanda J Roberts; Ricky Maung; Natalia E Sejbuk; Christopher Ake; Marcus Kaul
Journal:  J Neurosci Methods       Date:  2009-11-13       Impact factor: 2.390

3.  CyPPA, a Positive SK3/SK2 Modulator, Reduces Activity of Dopaminergic Neurons, Inhibits Dopamine Release, and Counteracts Hyperdopaminergic Behaviors Induced by Methylphenidate.

Authors:  Kjartan F Herrik; John P Redrobe; Dorte Holst; Charlotte Hougaard; Karin Sandager-Nielsen; Alexander N Nielsen; Huifang Ji; Nina M Holst; Hanne B Rasmussen; Elsebet Ø Nielsen; Dorte Strøbæk; Paul D Shepard; Palle Christophersen
Journal:  Front Pharmacol       Date:  2012-02-13       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.